{"product_id":"synlab-business-model-canvas","title":"SYNLAB Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSYNLAB Business Model Canvas: Strategic Blueprint for Scaling Diagnostics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind SYNLAB’s business model—this in-depth Business Model Canvas reveals how the company creates value, scales diagnostics services, and captures market share across labs and B2B channels; ideal for investors, consultants, and founders seeking actionable, ready-to-use insights to benchmark strategy and accelerate decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic Healthcare Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStrategic collaborations with national health services across Europe enable SYNLAB to outsource routine and specialized diagnostics at scale, representing roughly 25% of group revenues (~€1.1bn of €4.4bn in 2024) and cutting public sector lab costs by an estimated 18% per patient while improving access to advanced tests.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 these agreements are increasingly integrated via shared digital health records and standardized reporting, supporting a 30% faster turnaround on referrals and enabling centralized billing that reduced admin costs by ~12% in pilot countries.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical and Biotech Companies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSYNLAB partners with pharmaceutical and biotech firms to run clinical-trial diagnostics and develop companion diagnostics, supporting \u0026gt;1,200 industry studies in 2024 and generating an estimated €220m in biotech-related revenue that year. These alliances supply SYNLAB’s regulated labs, high-throughput sequencing, and data analytics to validate targeted therapies and accelerate personalized-medicine approval timelines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical Equipment and Reagent Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLong-term supply agreements with global lab-tech leaders (eg, Roche, Siemens Healthineers) secure advanced platforms and steady reagents, supporting SYNLAB’s 2024 test volume ~200 million analyses and revenue €2.9bn; these deals often include co-development of automated workflows that raised throughput by ~15–25% in pilot sites.\u003c\/p\u003e\n\u003cp\u003eStrategic sourcing and bulk purchasing cut reagent costs and exposure—centralized procurement reduced unit costs ~8% in 2023—while dual-supplier policies and inventory buffers limit disruption risk for high-volume testing.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSYNLAB partners with universities and research centers to translate research into diagnostics, co-developing tests—especially in oncology, genetics, and infectious disease—yielding 20+ joint projects in 2024 and licensing deals that added €12M revenue that year.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e20+ joint projects (2024)\u003c\/li\u003e\n\u003cli\u003e€12M licensing revenue (2024)\u003c\/li\u003e\n\u003cli\u003eFocus: oncology, genetics, infectious disease\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVeterinary and Environmental Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePartnerships with veterinary clinics and environmental agencies let SYNLAB extend diagnostics to animals and ecosystems, using spare lab capacity to capture new revenue—veterinary diagnostics grew ~8% CAGR 2019–2024 and environmental testing demand rose ~6% CAGR, adding ~€120–200m addressable annual revenue in Europe per 2024 estimates.\u003c\/p\u003e\n\u003cp\u003eThese collaborations support One Health integration—joint programs can boost lab utilization by 5–12% and reduce incremental margin dilution while opening cross-sell of molecular panels and surveillance services.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e8% veterinary diagnostics CAGR (2019–2024)\u003c\/li\u003e\n\u003cli\u003e6% environmental testing CAGR (2019–2024)\u003c\/li\u003e\n\u003cli\u003e€120–200m European addressable market (2024 est.)\u003c\/li\u003e\n\u003cli\u003e5–12% potential lab utilization uplift\u003c\/li\u003e\n\u003cli\u003eEnables One Health integrated surveillance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSYNLAB partnerships drive €1.1bn (25%) revenue, 200M tests, cost cuts \u0026amp; €120–200m growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSYNLAB’s key partnerships drive ~25% group revenue (~€1.1bn\/€4.4bn in 2024), support \u0026gt;1,200 industry studies (2024) and ~200M tests (2024), cut reagent\/unit costs ~8% and admin costs ~12%, and expand vet\/env markets (8% and 6% CAGRs 2019–2024) adding €120–200m addressable revenue.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eShare of revenue\u003c\/td\u003e\n\u003ctd\u003e25% (€1.1bn)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTests\u003c\/td\u003e\n\u003ctd\u003e~200M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIndustry studies\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;1,200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCost savings\u003c\/td\u003e\n\u003ctd\u003eReagents −8%, Admin −12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVet\/env addressable\u003c\/td\u003e\n\u003ctd\u003e€120–200m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-written Business Model Canvas for SYNLAB capturing customer segments, channels, value propositions, revenue streams, key resources, activities, partners, cost structure, and governance with real-world alignment to the company’s diagnostic services and growth strategy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCompact one-page Business Model Canvas for SYNLAB that saves hours of structuring, clarifies core diagnostics, partnerships, and revenue streams for fast boardroom-ready reviews and team collaboration.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-Throughput Clinical Testing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSYNLAB processes over 300 million lab tests yearly across 30+ countries via a multi-site network, using robotics and LIMS-driven automation to cut turnaround to 24–48 hours for core panels and keep error rates below 0.1%; standardized SOPs and ISO 15189 compliance plus daily KPI monitoring ensure adherence to diverse EU regulators, while lab ops represent ~40% of group OPEX and drive recurring revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLogistics and Sample Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eManaging movement of biological samples from 8,000+ collection points to SYNLAB’s central labs is core; in 2024 SYNLAB processed ~300 million tests, so a temperature-controlled transport network (cold chain at 2–8°C or -20°C) preserves integrity and lowers sample rejection rates below 0.5%. Efficient routing and 24\/7 courier links ensure median turnaround under 4 hours for acute-care and emergency-department critical tests.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Transformation and IT Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDevelopment and maintenance of SYNLAB’s proprietary laboratory information systems (LIS) manage test data flow and reporting across 30+ countries, supporting ~10 million tests\/month; ongoing IT dev improves doctor\/patient portals to cut result delivery time by up to 40% (median reduction from 48 to 29 hours in pilot sites, 2024).\u003c\/p\u003e\n\u003cp\u003eInvestment in cybersecurity and data privacy receives ~8–10% of IT budget annually (SYNLAB peers report €15–25m\/year for regional networks); this funds ISO 27001, GDPR compliance, multi-factor access and encryption to protect PHI (personal health information) across cloud and on-prem systems.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Diagnostic Research\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSYNLAB invests heavily in R\u0026amp;D to expand its test menu into advanced genetic and molecular diagnostics, validating methods and integrating AI for image analysis—R\u0026amp;D spend was ~€90m in 2024 (up 8% YoY) to capture higher-margin segments.\u003c\/p\u003e\n\u003cp\u003eStaying ahead in diagnostics secures referrals and pricing power: molecular tests grew ~15% in 2024 and represent ~22% of revenues in specialized testing lines.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e€90m R\u0026amp;D (2024)\u003c\/li\u003e\n\u003cli\u003eAI-assisted image analysis—validation pipelines\u003c\/li\u003e\n\u003cli\u003e15% growth in molecular tests (2024)\u003c\/li\u003e\n\u003cli\u003e22% revenue share from specialized testing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eQuality Assurance and Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSYNLAB enforces ISO-accredited quality systems across 500+ labs globally, with routine audits and external proficiency testing yielding \u0026gt;99.5% result concordance in 2024 to preserve clinical precision and payer confidence.\u003c\/p\u003e\n\u003cp\u003eCompliance teams track regulatory changes in 35+ countries, spending ~€30M annually on certifications, IT security, and audit remediation to sustain market access and reduce legal risk.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e500+ labs under ISO\/ accreditation\u003c\/li\u003e\n\u003cli\u003e\u0026gt;99.5% result concordance (2024)\u003c\/li\u003e\n\u003cli\u003e35+ jurisdictions monitored\u003c\/li\u003e\n\u003cli\u003e€30M compliance spend (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSYNLAB: 500+ ISO labs, ~300M tests\/yr, 22% specialized revenue, \u0026lt;0.5% rejections\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSYNLAB runs 500+ ISO-accredited labs, processing ~300M tests\/year (2024) with ~40% group OPEX in lab ops; R\u0026amp;D €90M and compliance €30M (2024) support 22% revenue from specialized\/molecular tests (15% growth 2024), LIS\/AI scale 10M tests\/month, cold-chain across 8,000+ collection points keeps sample rejection \u0026lt;0.5%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTests\/year\u003c\/td\u003e\n\u003ctd\u003e~300M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLabs (ISO)\u003c\/td\u003e\n\u003ctd\u003e500+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e€90M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompliance spend\u003c\/td\u003e\n\u003ctd\u003e€30M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialized rev%\u003c\/td\u003e\n\u003ctd\u003e22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMolecular growth\u003c\/td\u003e\n\u003ctd\u003e15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCollection points\u003c\/td\u003e\n\u003ctd\u003e8,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSample rejection\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;0.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Document Unlocks After Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you’re previewing is the exact SYNLAB Business Model Canvas you’ll receive—no mockup, no filler. When you purchase, you’ll get this same professional file ready to download and use, formatted for editing and presentation in Word and Excel. This preview reflects the full deliverable so there are no surprises: same content, same layout, instant access upon purchase.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749577372025,"sku":"synlab-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/synlab-business-model-canvas.png?v=1772215441","url":"https:\/\/matrixbcg.com\/products\/synlab-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}